Penumbra

PEN · NYSE

$324.34+$1.93 (+0.60%)TodayMarket closed · Oct 20, 7:39 PM ET

Prev close $322.41

Latest news

Press releaseOct 20, 9:00 AM ETPRNewswire
Penumbra's CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT)
Press releaseOct 6, 9:00 AM ETPRNewswire
New STORM-PE Data Demonstrate Correlation Between Clinical Assessments and Real-world Functional Recovery Captured Through Wearable Technology in Patients with Pulmonary Embolism
NewsJul 30, 5:03 PM ET
Penumbra Q2 EPS $0.88 Misses $1.20 Estimate, Sales $390.046M Beat $389.009M Estimate
Press releaseJul 30, 4:05 PM ETPRNewswire
Penumbra, Inc. Reports Second Quarter 2026 Financial Results
Press releaseJul 22, 2:35 PM ETPRNewswire
THUNDER Study Demonstrates Penumbra's THUNDERBOLT is Safe and Effective for Stroke Care
Press releaseJul 7, 9:00 AM ETPRNewswire
First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke
Press releaseJun 15, 9:00 AM ETPRNewswire
Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT
Press releaseJun 11, 4:05 PM ETPRNewswire
Penumbra's THUNDERBOLT Receives FDA Clearance - Bringing Computer Assisted Vacuum Thrombectomy Technology to Stroke
NewsMay 6, 5:17 PM ET
Penumbra Q1 Adj. EPS $1.00 Misses $1.07 Estimate, Sales $374.758M Beat $371.104M Estimate
Press releaseApr 13, 9:00 AM ETPRNewswire
New STORM-PE Data Show Computer Assisted Vacuum Thrombectomy with Anticoagulation Resulted in Significantly Better Functional Outcomes at 90 Days Compared to Anticoagulation Alone for Pulmonary Embolism Patients
Press releaseApr 10, 1:41 PM ETPRNewswire
Are OMEX, PEN, SNCY, CWAN Obtaining Fair Deals for their Shareholders?
Press releaseApr 7, 10:04 PM ETBusiness Wire
Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PEN
Press releaseMar 31, 11:19 AM ETPRNewswire
Are EHAB, SLAB, PEN, SKYT Obtaining Fair Deals for their Shareholders?
Press releaseMar 30, 1:35 PM ETPRNewswire
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--SLAB, PEN, SKYT, and EHAB
NewsMar 10, 12:42 PM ETTim Melvin
8 Stocks to Buy as Merger-Mania Takes Over
Press releaseMar 2, 4:39 PM ETPRNewswire
Are PEN, STKL, BCO, LNKB Obtaining Fair Deals for their Shareholders?
NewsFeb 25, 1:04 PM ET
Penumbra Q4 Earnings Assessment
NewsFeb 25, 1:03 PM ET
Penumbra Q4 Adj. EPS $1.18 Beats $1.11 Estimate, Sales $385.385M Beat $366.795M Estimate
Press releaseFeb 25, 1:00 PM ETPRNewswire
Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
NewsFeb 25, 12:59 PM ET
Penumbra Shares Halted, News Pending
Press releaseFeb 4, 6:30 AM ETPRNewswire
Boston Scientific announces results for fourth quarter and full year 2025
Press releaseJan 28, 6:41 PM ETPRNewswire
Halper Sadeh LLC Encourages PEN, RAPT, LSTA Shareholders to Contact the Firm to Discuss Their Rights
Press releaseJan 28, 2:23 PM ETPRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, RAPT, NATH, and LSTA
NewsJan 23, 12:00 PM ET
Price Over Earnings Overview: Penumbra
Press releaseJan 21, 3:58 PM ETPRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, DBRG, FFIC, and EXAS
NewsJan 21, 12:30 PM ETVandana Singh
Boston Scientific Advises Removal Of Certain AXIOS Stents After Deployment Issues Surface
Press releaseJan 21, 12:41 AM ETPRNewswire
Halper Sadeh LLC Encourages PEN, FONR, GDOT Shareholders to Contact the Firm to Discuss Their Rights
Press releaseJan 16, 2:06 PM ETPRNewswire
Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PEN
NewsJan 16, 8:01 AM ET
Analyst Expectations For Penumbra's Future
Press releaseJan 15, 3:30 PM ETPRNewswire
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Penumbra, Inc. (NYSE: PEN)
NewsJan 15, 1:11 PM ETPiero Cingari
Wall Street Soars Near Records, AMD And ASML Jump 6%: What's Moving Markets Thursday?
Press releaseJan 15, 10:27 AM ETPRNewswire
Shareholder Alert: The Ademi Firm investigates whether Penumbra, Inc. is obtaining a Fair Price for its Public Shareholders
NewsJan 15, 8:42 AM ETAkanksha Bakshi
Boston Scientific Acquires Penumbra In $14.5 Billion Bet To Dominate Thrombectomy
Press releaseJan 15, 8:29 AM ETBusiness Wire
PEN Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Penumbra, Inc. is Fair to Shareholders
Press releaseJan 15, 7:00 AM ETPRNewswire
Penumbra, Inc. Provides Preliminary Update on Fourth Quarter and Full Year 2025 Financial Results
Press releaseJan 15, 7:00 AM ETPRNewswire
Boston Scientific announces agreement to acquire Penumbra, Inc.
NewsJan 13, 1:04 PM ETPiero Cingari
Silver Jumps To $89 After Soft CPI, JPMorgan Falls 3%: What's Moving Markets Tuesday?
NewsNov 6, 12:42 PM ETAvi Kapoor
Datadog, Fastly, Planet Fitness, Air Products And Other Big Stocks Moving Higher On Thursday
NewsNov 5, 9:00 AM ET
A Look Into Penumbra Inc's Price Over Earnings
NewsDec 11, 12:00 PM ET
Price Over Earnings Overview: Penumbra

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Penumbra's CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT)

New STORM-PE Data Demonstrate Correlation Between Clinical Assessments and Real-world Functional Recovery Captured Through Wearable Technology in Patients with Pulmonary Embolism

Penumbra Q2 EPS $0.88 Misses $1.20 Estimate, Sales $390.046M Beat $389.009M Estimate

Penumbra, Inc. Reports Second Quarter 2026 Financial Results

THUNDER Study Demonstrates Penumbra's THUNDERBOLT is Safe and Effective for Stroke Care

First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke

Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT

Penumbra's THUNDERBOLT Receives FDA Clearance - Bringing Computer Assisted Vacuum Thrombectomy Technology to Stroke

Penumbra Q1 Adj. EPS $1.00 Misses $1.07 Estimate, Sales $374.758M Beat $371.104M Estimate

New STORM-PE Data Show Computer Assisted Vacuum Thrombectomy with Anticoagulation Resulted in Significantly Better Functional Outcomes at 90 Days Compared to Anticoagulation Alone for Pulmonary Embolism Patients

Are OMEX, PEN, SNCY, CWAN Obtaining Fair Deals for their Shareholders?

Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PEN

Are EHAB, SLAB, PEN, SKYT Obtaining Fair Deals for their Shareholders?

SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--SLAB, PEN, SKYT, and EHAB

8 Stocks to Buy as Merger-Mania Takes Over

Are PEN, STKL, BCO, LNKB Obtaining Fair Deals for their Shareholders?

Penumbra Q4 Earnings Assessment

Penumbra Q4 Adj. EPS $1.18 Beats $1.11 Estimate, Sales $385.385M Beat $366.795M Estimate

Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

Penumbra Shares Halted, News Pending

Boston Scientific announces results for fourth quarter and full year 2025

Halper Sadeh LLC Encourages PEN, RAPT, LSTA Shareholders to Contact the Firm to Discuss Their Rights

$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, RAPT, NATH, and LSTA

Price Over Earnings Overview: Penumbra

$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, DBRG, FFIC, and EXAS

Boston Scientific Advises Removal Of Certain AXIOS Stents After Deployment Issues Surface

Halper Sadeh LLC Encourages PEN, FONR, GDOT Shareholders to Contact the Firm to Discuss Their Rights

Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PEN

Analyst Expectations For Penumbra's Future

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Penumbra, Inc. (NYSE: PEN)

Wall Street Soars Near Records, AMD And ASML Jump 6%: What's Moving Markets Thursday?

Shareholder Alert: The Ademi Firm investigates whether Penumbra, Inc. is obtaining a Fair Price for its Public Shareholders

Boston Scientific Acquires Penumbra In $14.5 Billion Bet To Dominate Thrombectomy

PEN Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Penumbra, Inc. is Fair to Shareholders

Penumbra, Inc. Provides Preliminary Update on Fourth Quarter and Full Year 2025 Financial Results

Boston Scientific announces agreement to acquire Penumbra, Inc.

Silver Jumps To $89 After Soft CPI, JPMorgan Falls 3%: What's Moving Markets Tuesday?

Datadog, Fastly, Planet Fitness, Air Products And Other Big Stocks Moving Higher On Thursday

A Look Into Penumbra Inc's Price Over Earnings

Price Over Earnings Overview: Penumbra